SIRS 2021

The M1/M4 Agonist Xanomeline in Combination With Trospium Is Effective for Acute Treatment of Schizophrenia: PANSS Responder and PANSS 5-Factor Analyses of a Phase 2 Placebo-Controlled Inpatient Trial